TriangleFOR PATIENTS · SOURCE READING
Treatment of Recurrent Papillary and Follicular Thyroid Cancer
Source: Thyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of recurrent papillary and follicular thyroid cancer may include the following:
Source links and citations
Surgery to remove the tumor with or without radioactive iodine therapy.
Source links and citations
Radioactive iodine therapy when the cancer can be found only by a thyroid scan and cannot be felt during a physical exam.
Source links and citations
Targeted therapy with a tyrosine kinase inhibitor (sorafenib, lenvatinib, cabozantinib, selpercatinib, pralsetinib, larotrectinib, or entrectinib).
External radiation therapy or intraoperative radiation therapy as palliative therapy to relieve symptoms and improve thequality of life.
Source links and citations
Chemotherapy.
A clinical trial of a targeted therapy.
Source links and citations
A clinical trial of immunotherapy.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice